GyroMark™ HT kits were designed to enable clinical researchers and drug developers to generate valuable research data much faster than typical ELISA kits. Traditional ELISAs can consume significant time, sample, and reagents. With the fully automated, walk-away system, up to 480 data points can be generated in a run. The initial launch includes five assays for important metabolic and toxicity biomarkers, such as GLP-1, Insulin, Clusterin, and KIM-1. Because the Gyrolab platform employs microfluidic technology with parallel processing, it offers many advantages in addition to reagent and time savings such as accuracy over a four-log dynamic range (compared to two logs for ELISAs), elimination of cross-talk and plate position artifacts, and simplified sample prep (only 1:2 dilution necessary) with reduced matrix interference.